PARKHOSPSNSEPark Medi World LimitedHighNeutral
Announced Tue, 12 May · 10:56 IST

Park Medi World Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Revenue Growth 20pctPat Growth 25pctResults View source PDF

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.3%1-day move
₹261.00
prior close
₹264.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-1.2-1.9-2.5-5.3-5.1-7.2-8.0-5.3-2.0+9.6+5.6+11.2
Up moveDown movePending
AI summary

Park Medi World Limited reported strong audited results for FY2026 (year ended March 31, 2026). Consolidated revenue grew 20.5% to ₹16,794 million from ₹13,936 million in FY2025, while consolidated PAT rose 27.1% to ₹2,739 million from ₹2,154 million, with EPS of ₹6.87. Standalone PAT surged over 5x to ₹366 million on revenue of ₹1,290 million, boosted by the company's December 2025 IPO and multiple hospital acquisitions (KPS Wellness, SVPD Healthcare, Mahip Hospital) during the year. The company commenced a new 350-bed multi-specialty hospital in Panchkula in April 2026. Statutory auditors issued an unmodified opinion with no going concern issues. One subsidiary's results remain unaudited and were included based on management-prepared figures.

Likely market impact

Strong earnings growth and expansion via acquisitions and new facility openings signal operational scale-up, though the large jump in standalone PAT reflects significant IPO-driven changes and should be viewed in the context of consolidated group performance.